AGRX Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2023-04-28 | 2022 | Al Altomari Chairperson & Chief | 600,554 | 0 | 0 | 0 | 43,842 | 840,792 |
| 2023-04-28 | 2022 | Paul Korner Chief Medical Officer | 442,000 | 0 | 0 | 0 | 38,402 | 545,860 |
| 2023-04-28 | 2021 | Geoffrey P. Gilmore Sr. VP, Chief Administrative Officer | 423,325 | 0 | 0 | 0 | 36,187 | 1,060,265 |
| 2023-04-28 | 2022 | Geoffrey P. Gilmore Sr. VP, Chief Administrative Officer | 429,492 | 0 | 0 | 0 | 49,428 | 544,378 |
| 2023-04-28 | 2021 | Al Altomari Chairperson & Chief | 594,445 | 0 | 0 | 0 | 30,376 | 2,226,830 |
| 2023-04-28 | 2021 | Paul Korner Chief Medical Officer | 439,167 | 0 | 0 | 0 | 35,924 | 875,593 |
| 2022-04-29 | 2020 | Geoffrey P. Gilmore Sr. VP, General Counsel | 402,500 | 100,000 | 28,501 | 165,000 | 34,034 | 1,272,359 |
| 2022-04-29 | 2021 | Paul Korner | 439,167 | 0 | 0 | 99,500 | 35,924 | 975,093 |
| 2022-04-29 | 2020 | Al Altomari Chairman & Chief | 554,783 | 0 | 75,001 | 310,145 | 29,124 | 2,396,219 |
| 2022-04-29 | 2021 | Al Altomari Chairman & Chief | 594,445 | 0 | 0 | 180,000 | 30,376 | 2,406,830 |
| 2022-04-29 | 2021 | Geoffrey P. Gilmore Sr. VP, General Counsel | 423,325 | 0 | 0 | 95,700 | 36,187 | 1,155,965 |
| 2021-04-23 | 2020 | Al Altomari Chairman & Chief | 554,783 | 0 | 75,001 | 310,145 | 29,124 | 2,396,219 |
| 2021-04-23 | 2019 | Al Altomari Chairman & Chief | 506,733 | 0 | 0 | 441,000 | 23,372 | 1,301,371 |
| 2021-04-23 | 2020 | Geoffrey P. Gilmore Sr. VP, General Counsel | 402,500 | 100,000 | 28,501 | 165,000 | 34,034 | 1,272,359 |
| 2021-04-23 | 2019 | Geoffrey P. Gilmore Sr. VP, General Counsel | 343,100 | 0 | 0 | 225,000 | 29,428 | 828,374 |
| 2021-04-23 | 2020 | Dennis P. Reilly | 376,833 | 0 | 27,751 | 153,000 | 20,928 | 1,106,563 |
| 2020-04-24 | 2019 | Robert G. Conway | 256,250 | 0 | 0 | 0 | 0 | 557,487 |
| 2020-04-24 | 2019 | Al Altomari Chairman & Chief | 506,733 | 0 | 0 | 0 | 0 | 1,301,371 |
| 2020-04-24 | 2018 | Al Altomari Chairman & Chief | 494,400 | 100,000 | 0 | 0 | 0 | 1,519,881 |
| 2020-04-24 | 2019 | Geoffrey P. Gilmore | 337,850 | 0 | 0 | 0 | 0 | 823,124 |
| 2019-04-25 | 2018 | Scott M. Coiante Sr. VP & Chief Financial | 321,400 | 100,000 | 55,602 | 70,700 | 28,353 | 872,735 |
| 2019-04-25 | 2017 | Al Altomari Chairman & Chief | 492,000 | 0 | 0 | 123,600 | 26,117 | 1,008,917 |
| 2019-04-25 | 2018 | Al Altomari Chairman & Chief | 494,400 | 100,000 | 122,186 | 149,550 | 23,305 | 1,519,881 |
| 2019-04-25 | 2017 | Elizabeth Garner, M.D., M.P.H Sr. VP & Chief Medical | 369,500 | 0 | 79,100 | 64,977 | 53,020 | 719,597 |
| 2019-04-25 | 2018 | Elizabeth Garner, M.D., M.P.H Sr. VP & Chief Medical | 371,300 | 100,000 | 64,235 | 81,700 | 50,124 | 964,039 |
| 2019-04-25 | 2017 | Scott M. Coiante Sr. VP & Chief Financial | 319,833 | 0 | 79,100 | 56,245 | 27,117 | 635,295 |
| 2018-04-25 | 2016 | Elizabeth Garner, M.D., M.P.H. Sr. VP and Chief Medical Officer | 358,750 | 0 | 0 | 126,200 | 47,479 | 888,829 |
| 2018-04-25 | 2017 | Al Altomari Chairman and Chief Executive Officer | 492,000 | 0 | 0 | 123,600 | 26,117 | 1,008,917 |
| 2018-04-25 | 2016 | Al Altomari Chairman and Chief Executive Officer | 471,667 | 0 | 296,500 | 240,000 | 21,474 | 1,425,641 |
| 2018-04-25 | 2017 | Scott Coiante Sr. VP and Chief Financial Officer | 319,833 | 0 | 79,100 | 56,245 | 27,711 | 635,889 |
| 2018-04-25 | 2016 | Scott Coiante Sr. VP and Chief Financial Officer | 310,000 | 0 | 0 | 100,500 | 24,018 | 810,718 |
| 2018-04-25 | 2017 | Elizabeth Garner, M.D., M.P.H. Sr. VP and Chief Medical Officer | 369,500 | 0 | 79,100 | 64,977 | 53,020 | 719,597 |
| 2017-04-24 | 2016 | Al Altomari Chairman and Chief | 471,667 | 240,000 | 296,500 | 0 | 21,474 | 1,425,641 |
| 2017-04-24 | 2015 | Elizabeth Garner, M.D., M.P.H. Sr. VP and Chief Medical | 345,000 | 121,300 | 0 | 0 | 45,297 | 1,136,280 |
| 2017-04-24 | 2016 | Elizabeth Garner, M.D., M.P.H. Sr. VP and Chief Medical | 358,750 | 126,200 | 0 | 0 | 47,479 | 888,829 |
| 2017-04-24 | 2015 | Scott Coiante Sr. VP and Chief | 295,833 | 127,100 | 0 | 0 | 22,050 | 913,495 |
| 2017-04-24 | 2016 | Scott Coiante Sr. VP and Chief | 310,000 | 100,500 | 0 | 0 | 24,018 | 810,718 |
| 2017-04-24 | 2015 | Al Altomari Chairman and Chief | 425,000 | 236,500 | 0 | 0 | 19,257 | 1,805,186 |
| 2016-04-25 | 2015 | Al Altomari President and Chief Executive | 425,000 | 236,500 | 0 | 0 | 19,257 | 1,805,186 |
| 2016-04-25 | 2014 | Elizabeth Garner, M.D., M.P.H. Chief Medical Officer | 315,960 | 108,000 | 0 | 0 | 43,691 | 2,053,108 |
| 2016-04-25 | 2015 | Elizabeth Garner, M.D., M.P.H. Chief Medical Officer | 345,000 | 121,300 | 0 | 0 | 45,297 | 1,136,280 |
| 2016-04-25 | 2014 | Scott Coiante Chief Financial Officer | 250,000 | 76,300 | 0 | 0 | 21,752 | 1,568,382 |
| 2016-04-25 | 2015 | Scott Coiante Chief Financial Officer | 295,833 | 127,100 | 0 | 0 | 22,050 | 913,495 |
| 2016-04-25 | 2014 | Al Altomari President and Chief Executive | 362,500 | 160,000 | 0 | 0 | 23,419 | 1,179,569 |
| 2015-04-29 | 2013 | Al Altomari President and Chief | 325,000 | 65,000 | 0 | 0 | 25,213 | 415,213 |
| 2015-04-29 | 2013 | Elizabeth Garner, M.D., M.P.H. Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2015-04-29 | 2014 | Elizabeth Garner, M.D., M.P.H. Chief Medical Officer | 315,960 | 108,000 | 0 | 0 | 43,691 | 2,053,108 |
| 2015-04-29 | 2013 | Scott Coiante Chief Financial Officer | 225,000 | 45,000 | 0 | 0 | 25,213 | 295,213 |
| 2015-04-29 | 2014 | Scott Coiante Chief Financial Officer | 250,000 | 76,300 | 0 | 0 | 21,752 | 1,568,382 |
| 2015-04-29 | 2014 | Al Altomari President and Chief | 362,500 | 160,000 | 0 | 0 | 23,419 | 1,179,569 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
